These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35621226)

  • 1. Pathogen reduction by ozone-biological activated carbon-based advanced water reclamation for reuse.
    Teel L; Pagilla K; Sundaram V; Li L; Guarin T; Haak L
    Water Environ Res; 2022 May; 94(5):e10726. PubMed ID: 35621226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protozoa reduction through secondary wastewater treatment in two water reclamation facilities.
    Teel L; Olivieri A; Danielson R; Delić B; Pecson B; Crook J; Pagilla K
    Sci Total Environ; 2022 Feb; 807(Pt 3):151053. PubMed ID: 34673065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot testing of direct and indirect potable water reuse using multi-stage ozone-biofiltration without reverse osmosis.
    Hooper J; Funk D; Bell K; Noibi M; Vickstrom K; Schulz C; Machek E; Huang CH
    Water Res; 2020 Feb; 169():115178. PubMed ID: 31670085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of pathogen control in direct potable reuse: Performance evaluation and QMRA of a full-scale 1 MGD advanced treatment train.
    Pecson BM; Triolo SC; Olivieri S; Chen EC; Pisarenko AN; Yang CC; Olivieri A; Haas CN; Trussell RS; Trussell RR
    Water Res; 2017 Oct; 122():258-268. PubMed ID: 28609729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying pathogen risks associated with potable reuse: A risk assessment case study for Cryptosporidium.
    Amoueyan E; Ahmad S; Eisenberg JNS; Pecson B; Gerrity D
    Water Res; 2017 Aug; 119():252-266. PubMed ID: 28475966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended field investigations of ozone-biofiltration advanced water treatment for potable reuse.
    Sundaram V; Pagilla K; Guarin T; Li L; Marfil-Vega R; Bukhari Z
    Water Res; 2020 Apr; 172():115513. PubMed ID: 32006773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace and bulk organics removal during ozone-biofiltration treatment for potable reuse applications.
    Sundaram V; Pagilla K
    Water Environ Res; 2020 Mar; 92(3):430-440. PubMed ID: 31411786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wastewater treatment plants discharges disseminated more Giardia than Cryptosporidium.
    Onursal A; Icgen B
    Water Environ Res; 2023 Feb; 95(2):e10839. PubMed ID: 36751137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Escherichia coli to enteric protozoa ratios in rivers: Implications for risk-based assessment of drinking water treatment requirements.
    Sylvestre É; Dorner S; Burnet JB; Smeets P; Medema G; Cantin P; Villion M; Robert C; Ellis D; Servais P; Prévost M
    Water Res; 2021 Oct; 205():117707. PubMed ID: 34619609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial community characterization in advanced water reclamation for potable reuse.
    Guarin TC; Li L; Pagilla KR
    Appl Microbiol Biotechnol; 2022 Apr; 106(7):2763-2773. PubMed ID: 35294588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot-scale evaluation of ozone and biological activated carbon for trace organic contaminant mitigation and disinfection.
    Gerrity D; Gamage S; Holady JC; Mawhinney DB; Quiñones O; Trenholm RA; Snyder SA
    Water Res; 2011 Feb; 45(5):2155-65. PubMed ID: 21288550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and poly-fluoroalkyl substances removal in multi-barrier advanced water purification system for indirect potable reuse.
    Li L; Haak L; Guarin TC; Teel L; Sundaram V; Pagilla KR
    Water Environ Res; 2024 Feb; 96(2):e10990. PubMed ID: 38291828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of sewage treatment technologies for the removal of Cryptosporidium sp. and Giardia sp.: Toward water circularity.
    Suarez P; Alonso JL; Gómez G; Vidal G
    J Environ Manage; 2022 Dec; 324():116320. PubMed ID: 36183529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-potable water reuse and the public health risks from protozoa and helminths: a case study from a city with a semi-arid climate.
    Chaudhary A; Rana S; Singh R; Gurian PL; Betancourt W; Kumar A; Kumar A
    J Water Health; 2023 Aug; 21(8):981-994. PubMed ID: 37632375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a fluorescence EEM-PARAFAC model for direct and indirect potable water reuse monitoring: Multi-stage ozone-biofiltration without reverse osmosis at Gwinnett County, Georgia, USA.
    Wells MJM; Funk D; Mullins GA; Bell KY
    Sci Total Environ; 2023 Aug; 886():163937. PubMed ID: 37149191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pathogen concentrations on removal of Cryptosporidium and Giardia by conventional drinking water treatment.
    Assavasilavasukul P; Lau BL; Harrington GW; Hoffman RM; Borchardt MA
    Water Res; 2008 May; 42(10-11):2678-90. PubMed ID: 18313095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen reduction requirements for direct potable reuse in Antarctica: evaluating human health risks in small communities.
    Barker SF; Packer M; Scales PJ; Gray S; Snape I; Hamilton AJ
    Sci Total Environ; 2013 Sep; 461-462():723-33. PubMed ID: 23770553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ozone-biofiltration for bulk organic removal and disinfection byproduct mitigation in potable reuse applications.
    Arnold M; Batista J; Dickenson E; Gerrity D
    Chemosphere; 2018 Jul; 202():228-237. PubMed ID: 29571143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of perfluoroalkyl and polyfluoroalkyl substances in potable reuse systems.
    Glover CM; Quiñones O; Dickenson ERV
    Water Res; 2018 Nov; 144():454-461. PubMed ID: 30071400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drinking water treatment processes for removal of Cryptosporidium and Giardia.
    Betancourt WQ; Rose JB
    Vet Parasitol; 2004 Dec; 126(1-2):219-34. PubMed ID: 15567586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.